tiprankstipranks
Trending News
More News >
Enfusion (ENFN)
NYSE:ENFN
US Market

Enfusion (ENFN) Income Statement

Compare
36 Followers

Enfusion Income Statement

Last quarter (Q4 2024), Enfusion's total revenue was $52.94M, an increase of 13.88% from the same quarter last year. In Q4, Enfusion's net income was $121.00K. See Enfusion’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 201.61M$ 174.53M$ 150.35M$ 111.70M$ 79.56M
Gross Profit
$ 136.74M$ 116.89M$ 103.25M$ 79.86M$ 58.21M
Operating Expenses
$ 130.58M$ 104.95M$ 115.21M$ 355.74M$ 52.13M
Depreciation and Amortization
$ 0.00$ 9.99M$ 6.60M$ 3.98M$ 2.29M
EBITDA
$ 6.16M$ 21.93M$ -5.62M$ -271.91M$ 8.37M
Operating Income
$ 6.16M$ 11.95M$ -11.96M$ -275.88M$ 6.07M
Other Income/Expenses
$ 1.23M$ -464.00K$ -225.00K$ -5.78M$ -1.58M
Pretax Income
$ 7.39M$ 11.48M$ -12.19M$ -281.66M$ 4.49M
Net Income
$ 2.82M$ 6.03M$ -13.26M$ -282.24M$ 4.06M
Per Share Metrics
Basic EPS
$ 0.02$ 0.10$ -0.16$ -4.30$ 0.04
Diluted EPS
$ 0.01$ 0.07$ -0.16$ -4.30$ 0.04
Weighted Average Shares Outstanding
92.05M 88.20M 85.39M 65.58M 113.05M
Weighted Average Shares Outstanding (Diluted)
129.55M 129.43M 85.39M 65.58M 113.05M
Currency in USD

Enfusion Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis